公司资料
OpGen 股价、新闻与催化剂
- 股票代码:
- OPGN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for OPGN.
公司概览
业务概览
OpGen was a molecular diagnostics company focused on infectious disease and rapid genomic testing before becoming a historical ticker. Its business centered on helping clinicians identify pathogens and resistance faster.
所在地与行业分类
OpGen was headquartered in the United States and traded on NASDAQ. It sat in diagnostics and molecular testing.
商业模式特征
The company depended on test adoption, commercialization, and hospital workflow integration. Investors historically watched revenue, reimbursement, and operational execution.
生物医药行业定位
OpGen belongs to the historical diagnostics infrastructure category. It is not a drug stock, but it supported the testing ecosystem that informs patient care.
未来催化剂
- OpGen is a legacy / closeout story, so the catalysts are any final strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on residual value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。